An experimental immunotherapy drug shows tumor shrinkage in prostate cancer patients, while Eli Lilly's selpercatinib reduces recurrence risk in early-stage lung cancer. A separate study reveals persistent racial disparities in curative treatment for lung cancer patients.
Eli Lilly has stockpiled $1.5 billion in inventory for Orforglipron ahead of an expected FDA decision in April. The oral weight-loss pill aims to compete with Novo Nordisk's recently approved oral Wegovy.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07595120 |
Application of Electromagnetic Navigation System in Pulmonary Nodule Localization |
NOT_YET_RECRUITING | NA |
| NCT07564557 |
Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512) |
RECRUITING | NA |
| NCT07412327 |
Prospective Phase II Clinical Study of Stereotactic Body Proton Therapy (SBPT) for Lung Cancer |
RECRUITING | NA |
| NCT06746324 |
Assessing AI for Detecting Lung Nodules and Cancer: Pre- and Post-Deployment Study |
WITHDRAWN | |
| NCT06733311 |
A Study Developing a Non-invasive Urine-based Proteomic Model for Early Lung Cancer Detection. |
RECRUITING | |
| NCT05555199 |
Injection of 99mTc-nanocolloid and ICG to Identify, Retrieve and Qualify TDLN in Early-stage NSCLC |
COMPLETED | NA |
| NCT04287712 |
Detection of Lung Cancer by Plasma Lipids |
COMPLETED |
